LORATADINE TABLETS

The Defense Logistics Agency awarded a delivery order, SPE2DP26F7485, to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the supply of 4 units of LORATADINE TABLETS under the National Stock Number 6505013770448. The total contract value is $80.04, with delivery scheduled for July 29, 2026, to the destination address at Fort Campbell, Kentucky. The order is issued under the master IDIQ contract SPE2DX25D9900 and operates on a firm-fixed-price basis with zero variance allowed in quantity. All items must be shipped via traceable means only, not parcel post, and are subject to FOB DESTINATION terms, meaning the contractor assumes all risks and transportation costs until delivery. Packaging must include the Tracking Charge Number W34GMT60580283 and be marked with the NSN and CAGE code, though no specific barcoding or preservation standards are mandated. Inspection and acceptance occur at the destination by the Government, with compliance tied to the contract specifications. The awardee is certified as both a Small Disadvantaged Business and a Woman-Owned Small Business, triggering associated federal reporting and compliance obligations under FAR provisions. Payment will be processed through the Defense Finance and Accounting Service using voucher-based methods to the remit-to address in Columbus, Ohio, under appropriation code BX: 97X4930 5CBX 001 2620 S33189. No additional contract clauses, attachments, or special requirements beyond logistics and business certification were specified, and no Contracting Officer’s Representative is designated. The award reflects a low-value, off-the-shelf pharmaceutical procurement processed under a Lowest Price Technically Acceptable framework, leveraging the awardee's socioeconomic status and standardized military supply channels.